Mycosis fungoides diagnostic study of choice

Mycosis fungoides Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Mycosis Fungoides from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
X-Ray
CT Scan
MRI
Echocardiography and Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Mycosis fungoides diagnostic study of choice On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Mycosis fungoides diagnostic study of choice All Images X-rays Echo and Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Mycosis fungoides diagnostic study of choice
CDC on Mycosis fungoides diagnostic study of choice
Mycosis fungoides diagnostic study of choice in the news
Blogs on Mycosis fungoides diagnostic study of choice
Directions to Hospitals Treating Mycosis fungoides
Risk calculators and risk factors for Mycosis fungoides diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Diagnostic Study of Choice

Mycosi fungoides must be performed when:

• The patient presents with symptomatic progressive skin lesions such as: patches, plaques, tumors, and erytheroderma, and a poorer prognosis in later stages.

There is no single diagnostic study of choice for the diagnosis of mycosis fungoides, and mycosis fungoides can be diagnosed difficult by nonspecific skin presentation.

Mycosis fungoides is primarily diagnosed based on the clinical presentation.